Literature DB >> 3683721

Effect of phosphatidylserine on acetylcholine release and content in cortical slices from aging rats.

M G Vannucchi1, G Pepeu.   

Abstract

Cortical slices were prepared from male rats 3 to 28 months old. The slices were superfused with choline-enriched Krebs solution containing physostigmine and electrically stimulated at frequencies of 1, 2 and 5 Hz for 5 min periods preceded and followed by rest periods. The amount of acetylcholine released during the stimulation periods was quantified by bioassay. In some experiments acetylcholine content was measured at the end of the superfusion period in stimulated and unstimulated slices. The evoked acetylcholine release was constant between 3 and 11 months of age at each frequency tested and showed a 50% decrease between 11 and 14 months of age with no further decrease up to 28 months. No difference in the evoked acetylcholine release was detected between 3 and 16 month old rats if the old rats were pretreated with phosphatidylserine 15 mg/kg IP for at least 7 days. The effect of phosphatidylserine lasted for 5 days after interruption of the treatment. There was no difference in acetylcholine content between the stimulated and unstimulated slices in 3 month old rats. In 16 month old rats stimulation brought about a 44% decrease in acetylcholine content. This decrease did not occur in rats pretreated with phosphatidylserine for 7 days. Phosphatidylserine appears to restore acetylcholine release in aging rats by maintaining an adequate acetylcholine supply in the slices.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683721     DOI: 10.1016/0197-4580(87)90034-0

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

Review 1.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

2.  Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats.

Authors:  A Zanotti; L Valzelli; G Toffano
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study.

Authors:  Yael Richter; Yael Herzog; Tzafra Cohen; Yael Steinhart
Journal:  Clin Interv Aging       Date:  2010-11-02       Impact factor: 4.458

4.  Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men.

Authors:  P Monteleone; M Maj; L Beinat; M Natale; D Kemali
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Serine metabolism in the brain regulates starvation-induced sleep suppression in Drosophila melanogaster.

Authors:  Jun Young Sonn; Jongbin Lee; Min Kyung Sung; Hwajung Ri; Jung Kyoon Choi; Chunghun Lim; Joonho Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

6.  Suspected cholinergic toxicity due to cevimeline hydrochloride and Bacopa monnieri interaction: a case report.

Authors:  Blake Acquarulo; Priya Tandon; Carolyn M Macica
Journal:  J Med Case Rep       Date:  2022-06-29

Review 7.  Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases.

Authors:  Andrzej Szutowicz; Hanna Bielarczyk; Agnieszka Jankowska-Kulawy; Tadeusz Pawełczyk; Anna Ronowska
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

8.  A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the Phospholipid Intervention for Cognitive Ageing Reversal (PLICAR): study protocol for a randomized controlled trial.

Authors:  Andrew B Scholey; David A Camfield; Matthew E Hughes; Will Woods; Con K K Stough; David J White; Shakuntla V Gondalia; Pernille D Frederiksen
Journal:  Trials       Date:  2013-11-26       Impact factor: 2.279

9.  Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.

Authors:  Woojin Scott Kim; Eve Jary; Russell Pickford; Ying He; Rebekah M Ahmed; Olivier Piguet; John R Hodges; Glenda M Halliday
Journal:  Front Neurol       Date:  2018-02-28       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.